Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2001
04/26/2001WO2001028321A1 Diabetes onset model mammal
04/26/2001WO2001009335A3 Moraxella catarrhalis antigen basb120
04/26/2001WO2001005970A3 Gtp-binding protein associated factors
04/26/2001WO2001005953A3 Maize ethylene signalling pathway ein3 genes and uses thereof
04/26/2001WO2001005934A3 Feline calicivirus genes and vaccines, in particular recombined vaccines
04/26/2001WO2000078958A3 Scorpion toxins from buthotus judaicus
04/26/2001WO2000077040A3 Human intracellular signaling molecules
04/26/2001WO2000071723A3 Methods for regulating protein conformation using molecular chaperones
04/26/2001WO2000066753A3 Modified vitamin k-dependent polypeptides
04/26/2001WO2000066743A3 Viral expression vectors
04/26/2001WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression
04/26/2001WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer
04/26/2001WO2000060088A3 Plant viral movement protein genes
04/26/2001WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/26/2001WO2000053734A3 Human angiogenesis relevant nucleic acid and protein sequences obtained from endothelial cells
04/26/2001WO2000052151A3 Human secretory proteins
04/26/2001US20010000488 Transforming the host cell with nucleic acid encoding the polypeptide factor, transforming host cell with nucleic acid coding desired protein and culturing the transformed host cell in a medium lacking the polypeptide factor
04/26/2001CA2391940A1 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase
04/26/2001CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
04/26/2001CA2388427A1 Methods for improving secondary metabolite production in fungi
04/26/2001CA2388421A1 Human cub-domain-containing protein and gene encoding the same
04/26/2001CA2388386A1 A new eag gene
04/26/2001CA2388032A1 Polynucleotides encoding human and murine adhesion proteins (bigr)
04/26/2001CA2388003A1 Expression of recombinant mature lysostaphin
04/26/2001CA2387991A1 Production of protein in insect larvae using a transposon-based expression system
04/26/2001CA2387962A1 A dna molecule encoding a variant .alpha.2b-adrenoceptor protein, and uses thereof
04/26/2001CA2387928A1 Genes associated with obesity and methods for using the same
04/26/2001CA2387864A1 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
04/26/2001CA2387810A1 Novel human proteins and polynucleotides encoding the same
04/26/2001CA2387731A1 P15paf cell cycle proteins associated with pcna, compositions and methods of use
04/26/2001CA2387646A1 A general method for optimizing the expression of heterologous proteins
04/26/2001CA2387559A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent
04/26/2001CA2387392A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase
04/26/2001CA2387043A1 Colon-tumour-associated antigens
04/26/2001CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof
04/26/2001CA2387031A1 Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
04/26/2001CA2386922A1 Novel polypeptides and polynucleotides encoding same
04/26/2001CA2386596A1 Novel germinal center kinase cell cycle proteins, compositions and methods of use
04/26/2001CA2386476A1 Tms1 compositions and methods of use
04/26/2001CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy
04/26/2001CA2386270A1 Rna interference pathway genes as tools for targeted genetic interference
04/26/2001CA2384841A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies
04/26/2001CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies
04/25/2001EP1094317A1 Method to identify compounds which modulate FRA-1 expression
04/25/2001EP1094118A1 Enzymatic conversion of precursor proteins using a dictyostelium dipeptidylaminopeptidase
04/25/2001EP1094115A1 (-)-strand rna virus vector for nerve cell
04/25/2001EP1094110A1 Apoptosis inducing proteinaceous substance
04/25/2001EP1094109A2 Human G protein-coupled receptor, PFI-010
04/25/2001EP1094108A2 DNA mutagenesis by random fragmentation and reassembly for antibody production
04/25/2001EP1094081A1 Fused protein with direct bond of il-6-receptor to il-6
04/25/2001EP1094079A2 Stable polymerized hemoglobin blood-substitute
04/25/2001EP1094078A2 Stable polymerized hemoglobin blood-substitute
04/25/2001EP1094077A1 Novel sugar chain-bonded thrombomodulin-like peptide
04/25/2001EP1094076A1 Human G-protein coupled receptor
04/25/2001EP1094075A1 Human G-protein coupled receptor
04/25/2001EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses
04/25/2001EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis
04/25/2001EP1094072A1 Peptides having corticotropin releasing factor (CRF) antagonist activity
04/25/2001EP1094071A1 Novel peptide y-2
04/25/2001EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials
04/25/2001EP1094069A1 DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof
04/25/2001EP1093822A2 Oral immunology using plant product containing a non-enteric pathogen antigen
04/25/2001EP1093821A2 Oral immunology using plant product containing a non-enteric pathogen antigen
04/25/2001EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen
04/25/2001EP1093720A1 Stable polymerized hemoglobin blood-substitute
04/25/2001EP1093524A1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
04/25/2001EP1093523A1 Maize rad50 orthologue and uses of therof
04/25/2001EP1093522A2 Proteases fused with variants of stretptomyces subtilisin inhibitor
04/25/2001EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
04/25/2001EP1093518A2 Stabilized variants of streptomyces subtilisin inhibitor
04/25/2001EP1093517A2 Neisseria meningitidis antigens and compositions
04/25/2001EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
04/25/2001EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
04/25/2001EP1093464A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
04/25/2001EP1093463A1 A method for preparing a compound with growth hormone releasing properties
04/25/2001EP1093462A1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection
04/25/2001EP1093461A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses
04/25/2001EP1093459A2 Chemically modified proteins with a carbohydrate moiety
04/25/2001EP1093458A1 Process for the preparation of resin-bound cyclic peptides
04/25/2001EP1093457A1 Cytokine receptor common gamma chain like
04/25/2001EP1093359A1 Method for preparing fibrillin from cnidaria, and resulting compositions useful in cosmetics
04/25/2001EP1093333A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants
04/25/2001EP0986641A4 Grapevine leafroll virus (type 2) proteins and their uses
04/25/2001EP0812129A4 Insecticidal peptides from spider venom
04/25/2001CN1292820A i (Neisseria meningitidis) antigens
04/25/2001CN1292817A Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing same
04/25/2001CN1292815A Resistance in plants to infection by ssDNA virus using i(inoviridae) virus ssDNA-binding protein, compositions and methods of use
04/25/2001CN1292798A Methods and compositions for treating and diagnosing insulin related disorders
04/25/2001CN1292638A Gene mutant animals
04/25/2001CN1292387A New polypeptide-human I kappa B kinase and polynucleotide coding this polypeptide
04/25/2001CN1292386A New polypeptide-HRMT 35 and polynucleotide coding this polypeptide
04/25/2001CN1292385A New polypeptide-human DNA-PK interaction protein 75 and polynucleotide coding this polypeptide
04/25/2001CN1292384A New polypeptide-zinc finger protein 64 and polynucleotide coding this polypeptide
04/25/2001CN1292383A New polypeptide-human glutamine enrichment factor 56 and polynucleotide coding this polypeptide
04/25/2001CN1292382A New polypeptide-ID-17 and polynucleotide coding this polypeptide
04/25/2001CN1064970C Non-densatured extraction method of medical collagen protein
04/25/2001CN1064969C Obtusatus arthrospira phycocyanin and its application
04/24/2001US6222097 Use of ovary-tissue transcriptional factors for altering plant color
04/24/2001US6222095 Sequences from auxin-induced gene products targeting fusion proteins for degradation
04/24/2001US6222094 Mammal whose germ and mammary gland cells contain dna coding for peptide of defined amino acid sequence, signal sequence for secretion, and functional promoter; recombinant production of infant formula